Combination Therapy with TZD and SGLT-2 Inhibitor: A Promising Treatment Strategy for Diabetes and Cardiovascular Health

Combination therapy involving a thiazolidinedione (TZD) and an SGLT-2 inhibitor has emerged as a promising strategy for the treatment of diabetes. This approach utilizes the distinct mechanisms of these two drugs to effectively manage blood sugar levels and reduce the occurrence of major cardiovascular complications. At the International Conference of the Korean Diabetes Association (ICDM […]